Firm at a glance
Proa Capital is a platform private equity firm headquartered in Madrid, Spain, per its own website [S1].
What they buy
Proa Capital’s portfolio reflects a diversified approach across Spanish and European middle-market companies [S2]. The firm’s investments span healthcare (including medical devices, nutrition, and fertility clinics), consumer products (ranging from art supplies to mobile accessories), food and beverage, technology services, and industrial manufacturing. The portfolio suggests a focus on established businesses with market-leading positions in their respective niches, predominantly based in Spain and neighboring markets.
Portfolio
Proa Capital’s portfolio includes approximately 30 companies across multiple sectors [S2]:
**Healthcare:** Klockner Medical Group, Adventia Nutrición Médica, Hospital Llevant, Clinica Eugin, Health Transportation Group, Avizor (contact lens solutions), and Suanfarma (pharmaceutical manufacturing).
**Consumer Products & Retail:** Acrylicos Vallejo (acquired December 2023), La Casa de las Carcasas (mobile accessories), Gallo (consumer goods), and Amara (baby products).
**Food & Beverage:** Grupo Palacios, Delafruit, and Grupo Vips (restaurant group).
**Industrial & Manufacturing:** BAT Group, HIJOLUSA, Neoelectra, MASA, MOYCA, RELEVI, Avioparts (acquired September 2023), MAW, Unolab Manufacturing, and Rotor.
**Technology & Services:** ISEAZY (acquired May 2023), IPD, Ibermática (IT services), SOMOS, and Grupo Solitium.
**Infrastructure:** Saba (parking facilities).
Recent activity (last 24 months)
* **December 2023:** Acquired Acrylicos Vallejo, an art supplies manufacturer [S3]
* **October 2024:** Exited Avioparts, an aerospace components business [S3]
How this firm fits a seller
Proa Capital appears suited for owner-operators of established middle-market businesses in Spain and Southern Europe seeking a buyer with regional expertise and a track record across diverse sectors. The firm’s portfolio demonstrates experience managing both B2B and B2C companies, suggesting operational flexibility. The recent exit of Avioparts in October 2024 indicates active portfolio management and the ability to execute liquidity events for founders and management teams [S3]. Businesses in healthcare, specialty manufacturing, or branded consumer products may find sector alignment with the firm’s existing investment themes.
Sources
[S1] https://proacapital.com/about-us/ (as of 2025-01-10)
[S2] https://proacapital.com/portfolio/ (as of 2025-01-10)
[S3] https://proacapital.com/news/ (as of 2025-01-10)
Frequently asked questions
Does Proa Capital buy healthcare businesses?
Yes, healthcare represents a significant portion of Proa Capital’s portfolio, per public sources as of January 2025 [S2]. The firm’s healthcare investments include medical device distributors (Klockner Medical Group), medical nutrition (Adventia Nutrición Médica), hospitals (Hospital Llevant), fertility clinics (Clinica Eugin), and healthcare transportation services, indicating sustained interest in the sector.
What companies has Proa Capital acquired recently?
Proa Capital’s most recent publicly disclosed acquisitions include Acrylicos Vallejo in December 2023, ISEAZY in May 2023, and Avioparts in September 2023 [S2][S3]. These transactions span art supplies manufacturing, e-learning technology, and aerospace components respectively, demonstrating the firm’s sector-diverse investment approach.
Where is Proa Capital based and how big is the firm?
Proa Capital is based in Madrid, Spain, with its office located in the Spanish capital [S1]. The firm maintains approximately 30 portfolio companies across its investment history [S2]. Fund size and assets under management were not publicly disclosed in available sources as of January 2025.
Is Proa Capital still actively acquiring?
Yes, Proa Capital appears to remain active, with its most recent acquisition (Acrylicos Vallejo) completed in December 2023 and a portfolio exit (Avioparts) executed in October 2024 [S3]. This recent transaction activity within the last 15 months suggests ongoing investment and portfolio management operations.
This profile is maintained by CT Acquisitions as an independent third-party reference. CT Acquisitions is not affiliated with, endorsed by, or a representative of the firm profiled. All facts sourced from publicly available materials as of the dates cited.